Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11075	Companies
243007	Keywords
171154	Articles
130792	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 10/30/2025 at 22:59, 10 months 24 days ago

Biophytis Reports First-Half 2025 Results and Provides Strategic Update
Biophytis reports financial results for the first half of 2025, strategic update, and key achievements in sarcopenia and obesity. Plans for Phase 2 and Phase 3 studies outlined with focus on sustaining growth and value creation

Financial Results Biophytis Sarcopenia Strategic Update Obesity
BRIEF

published on 10/13/2025 at 07:05, 11 months 11 days ago

Biophytis and Asian Investors to Launch Phase 3 Sarcopenia Trial

Biophytis Phase 3 Trial Sarcopenia BIO101 Asian Investors
BRIEF

published on 10/13/2025 at 07:05, 11 months 11 days ago

Biophytis et Partenaires Asiatiques Lancent un Essai Clinique Historique

Biophytis Essai Clinique Sarcopénie BIO101 Coentreprise Hong Kong
REGULATED PRESS RELEASE

published on 10/13/2025 at 07:00, 11 months 11 days ago

BIOPHYTIS et un consortium d’investisseurs incluant RONGHUI RENHE Life Technology unissent leurs forces pour financer et lancer le tout premier essai clinique de Phase 3 dans la sarcopénie
BIOPHYTIS et un consortium d'investisseurs lancent le premier essai clinique de Phase 3 dans la sarcopénie, avec une coentreprise à Hong Kong et un investissement de 20 M$. Opérations cliniques prévues début 2026

Biophytis Investisseurs Essai Clinique Coentreprise Sarcopénie
REGULATED PRESS RELEASE

published on 10/13/2025 at 07:00, 11 months 11 days ago

BIOPHYTIS and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in Sarcopenia
BIOPHYTIS and a Consortium of Investors partner to finance and launch Phase 3 Trial in Sarcopenia, creating a joint venture in Hong Kong with US$20 million investment for clinical operations starting early 2026

Biophytis Joint Venture Phase 3 Trial Sarcopenia Consortium Of Investors
PRESS RELEASE

published on 10/13/2025 at 06:59, 11 months 11 days ago

BIOPHYTIS et un consortium d’investisseurs incluant RONGHUI RENHE Life Technology unissent leurs forces pour financer et lancer le tout premier essai clinique de Phase 3 dans la sarcopénie
Biophytis et un consortium d'investisseurs, dont Ronghui Renhe Life Technology, s'unissent pour lancer l'essai clinique de Phase 3 en sarcopénie, avec une coentreprise à Hong-Kong

Biophytis Essai Clinique Coentreprise Sarcopénie Consortium D'investisseurs
BRIEF

published on 09/30/2025 at 07:05, 11 months 24 days ago

Biophytis Renforce Sa Présence sur la Scène Internationale au 4ème Trimestre 2025

Biophytis Partenariats Sarcopénie Biotechnologies Événements Internationaux
BRIEF

published on 09/30/2025 at 07:05, 11 months 24 days ago

Biophytis to Engage in Key Events in Q4 2025

Biophytis Partnerships Longevity Sarcopenia Biotechnology Events
REGULATED PRESS RELEASE

published on 09/30/2025 at 07:00, 11 months 24 days ago

Biophytis annonce sa participation à quatre événements clés au cours du 4ème trimestre 2025
Biophytis annonce sa participation à quatre événements clés internationaux au 4ème trimestre 2025 pour présenter ses avancées dans la santé et renforcer ses partenariats

Biophytis Développement Participation Événements Clés 4ème Trimestre 2025
REGULATED PRESS RELEASE

published on 09/30/2025 at 07:00, 11 months 24 days ago

Biophytis to Participate in Four Key Events in Q4 2025
Biophytis to participate in four major international events in Q4 2025, showcasing its progress in transformative therapies impacting longevity and seeking new partnerships

Biophytis Partnerships Longevity International Events Transformative Therapies

Accesswire

Published on 09/24/2026 at 14:55, 23 minutes ago

Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements
Published on 09/24/2026 at 14:30, 48 minutes ago

Solitario Resources CEO to Present at the 38th Annual Mining Forum Americas 2026 Conference
Published on 09/24/2026 at 14:00, 1 hour 18 minutes ago

Horizon Aircraft to Report First Quarter 2027 Results and Provide a Business Update on October 9, 2026
Published on 09/24/2026 at 14:00, 1 hour 18 minutes ago

Reeflex Completes $1.23 Million Goes Order on Schedule Ahead of Vancouver Investor Conference
Published on 09/24/2026 at 14:00, 1 hour 18 minutes ago

Nine Mile Metals DDH Wd-26-14 Intersects 5.09% Cu-Eq Over 14.15m Including 6.35% Cu-Eq Over 9m and 7.45% Cu-Eq Over 6m

View all ACCESSWIRE

EQS Group

Published on 09/24/2026 at 15:05, 12 minutes ago

Trustpilot Expands AI Discovery Suite With Dedicated Product Review Pages and New Brand Intelligence Tools
Published on 09/24/2026 at 15:05, 12 minutes ago

Ondo Launches Intelligent Portfolios, Powered by BlackRock, Bringing Portfolio Strategies Onchain
Published on 09/24/2026 at 15:05, 12 minutes ago

IPID Raises $16M as Instant Payments Expose a Growing Global Blind Spot
Published on 09/24/2026 at 14:47, 30 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 09/24/2026 at 14:47, 31 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc

Les Echos

Published on 09/24/2026 at 08:00, 7 hours 18 minutes ago

Neoen launches construction of 3 solar farms and a wind farm in France, with a total capacity of 101 MW
Published on 09/24/2026 at 08:00, 7 hours 18 minutes ago

Neoen lance la construction de trois parcs solaires et un parc éolien en France pour une capacité totale de 101 MW
Published on 09/24/2026 at 07:30, 7 hours 48 minutes ago

Gimv rondt met succes private plaatsing van een obligatie af voor een bedrag van EUR 150 miljoen
Published on 09/24/2026 at 07:30, 7 hours 48 minutes ago

Gimv successfully completes private placement of a bond for an amount of EUR 150 million
Published on 09/24/2026 at 07:30, 7 hours 48 minutes ago

Gimv successfully completes private placement of a bond for an amount of EUR 150 million

View all LES ECHOS COMFI WIRE